新型冠状病毒肺炎疫情之下儿童暴发性心肌炎合并高度或完全性房室传导阻滞介入治疗的思考与建议

付佳; 张勇

doi:10.13201/j.issn.1001-1439.2020.03.003

新型冠状病毒肺炎疫情之下儿童暴发性心肌炎合并高度或完全性房室传导阻滞介入治疗的思考与建议

付佳,
张勇^,

- 1 华中科技大学同济医学院附属武汉儿童医院(武汉市妇幼保健院)心内科(武汉, 430016)

详细信息

通讯作者: 张勇,E-mail:1539210298@qq.com

中图分类号: R725.4

收稿日期: 2020-02-16

Thoughts and suggestions on interventional therapy of fulminant myocarditis in children with severe atrioventricular block under the situation of COVID-19

FU Jia,
ZHANG Yong^,

- Department of Cardiology, Wuhan Children's Hospital, Wuhan Maternal and Child Healthcare Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430016, China

More Information

Corresponding author: ZHANG Yong, E-mail: 1539210298@qq.com

Received Date: 16 February 2020

摘要

摘要: 目前新型冠状病毒肺炎(COVID-19)疫情依旧严峻,人群普遍易感,儿童亦不能幸免,已有报道显示冠状病毒感染可能会引发暴发性心肌炎。暴发性心肌炎合并高度或完全性房室传导阻滞属于儿童心血管急危重症,此类患儿若药物治疗下生命体征仍不能稳定,无论在之前还是当前疫情严峻的情况下,均需紧急置入临时起搏器提供基础生命支持。在COVID-19流行的大环境下,制定好以及执行好其诊治过程和围手术期的防控策略尤为重要。
- 新型冠状病毒肺炎 /
- 暴发性心肌炎 /
- 高度或完全性房室传导阻滞 /
- 临时起搏器 /
- 防护
Abstract: COVID-19 is still severe,the population is generally susceptible,and children are not immune.It has been reported that the coronavirus infection can cause fulminant myocarditis.Fulminant myocarditis complicated with high grade atrioventricular block is a critical cardiovascular disease in children,if the vital signs of these children are still not stable under the treatment of drugs,patients need to temporary pacemakers to provide basic life support in the past or in the current severe situation.Under the background of COVID-19 epidemic,it is particularly important to formulate and implement the strategies of diagnosis,treatment,prevention and control.
- new coronavirus pneumonia /
- fulminant myocarditis /
- severe atrioventricular block /
- temporary pacemaker /
- prevention and control

HTML全文

参考文献(16)

[1]	湖北省卫生健康委员会.2020年2月7日湖北省新型冠状病毒感染的肺炎疫情情况[EB/OL].(2020-02-08)[2020-02-08].
[2]	陈锋,刘智胜,张芙蓉,等.中国首例儿童危重型新型冠状病毒肺炎[J].中华儿科杂志,2020,58:E005-E005.
[3]	Guan WJ,Ni ZY,Hu Y,et al.Clinical characteristics of 2019 novel coronavirus infection in China[J/OL].medRxiv.(2020-02-09)[2020-02-10].https://doi.org/10.1101/2020.02.06.20020.974.
[4]	Pollack A,Kontorovich A R,Fuster V,et al.Viral myocarditis--diagnosis,treatment options,and current controversies[J].Nat Rev Cardiol,2015,12(11):670-680.
[5]	Huang C,Wang Y,Li X,et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan,China[J].Lancet,2020,395(10223):497-506.
[6]	Xu X,Chen P,Wang J,et al.Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission[J].Sci China Life Sci,2020.[Online ahead of print].
[7]	中华医学会心血管病学分会,中华心血管病杂志编辑委员会.新型冠状病毒肺炎疫情防控期间心血管急危重症患者临床处理原则的专家共识[J].中华心血管病杂志,2020,48(00):E001-E001.
[8]	国家卫生健康委办公厅,国家中医药管理局办公室.新型冠状病毒感染的肺炎诊疗方案(试行第六版)[EB/OL].国卫办医函[2020]145号.2020-02-18[2020-02-18].
[9]	Holshue ML,DeBolt C,LindquistS,et al.First case of 2019 novel coronavirus in the United States[J].N Engl J Med,2020.[Epub ahead of print].
[10]	何俊美,魏秋华,任哲,等.在新型冠状病毒肺炎防控中口罩的选择和使用[J].中国消毒学杂志,2020,37(2):137-141.
[11]	全国人大常务委员会.中华人民共和国传染病防治法(2013修正)[EB/OL].(2013-06-29)[2020-02-06].http://www.gov.cn/banshi/2005-08/01/content_19023.htm.
[12]	国家卫生健康委员会.医疗机构感染预防与控制基本制度(试行)[EB/OL].(2019-05-18)[2020-02-06].http://www.nhc.gov.cn/yzygj/s7659/201905/d831719a5ebf450f991ce47baf944829.shtml.
[13]	国家卫生健康委员会.医疗机构内新型冠状病毒感染预防与控制技术指南(第一版)[EB/OL].(2020-01-22)[2020-02-06].http://www.nhc.gov.cn/yzygj/s7659/202001/b91fdab7c304431eb082d67847d27e14.shtml.
[14]	国家卫生健康委员会.新型冠病毒感染的肺炎防控中常见医用防护用品使用范围指引(试行)[EB/OL].(2020-01-27)[2020-02-06].http://www.nhc.gov.cn/yzygj/s7659/202001/e71c5de925a64eafbe1ce790debab5c6.shtml.
[15]	郭莉.2019版手术室护理实践指南[M].北京:人民卫生出版社,2019:98-105.
[16]	Lu R,Zhao X,Li J,et al.Genomic characterisation and epidemiology of 2019 novel coronavirus:implications for virus origins and receptor binding[J].Lancet,2020,pii:S0140-6736(20)30251-8.[Epub ahead of print].